Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
New version will update the design, handling, and opening mechanism.
January 14, 2025
By: Kristin Brooks
Vetter, a global CDMO, will launch the new version of its V-OVS syringe closure system, V-OVS next, to support a range of sterile injectables integrating several unique technical advances guided by shifting market needs and feedback from customers. The design of V-OVS next will be optimized to protect the integrity of the injectable product secured by the closure. For customers with products in glass-barrel syringes, this new closure will be an opportunity to integrate Luer Lock features with easier handling characteristics and more intuitive opening mechanism.
“With its tamper-evident features, we’re confident that V-OVS next will bring a new level of user-friendliness to Luer Lock applications,” said Tobias Nemeth, Director Primary Packaging Service & Projects at Vetter. “It will further build on the decades of market impact delivered by this industry-leading system and provide a differentiating choice for customers with an even wider range of injectable products.”
Additionally, the overall size will also be reduced to better fit smaller syringe sizes. New updated gripping surfaces are designed to provide optimal control during opening, and a new locking mechanism will help keep the closure safely in place even during the most challenging clinical use cases.
V-OVS next is scheduled to launch in 2027. As part of its go-to-market preparations, Vetter recently conducted a successful human factors study with a representative group of frontline clinical users. The study delivered consistent positive feedback and insights that will directly contribute to finalizing the design of the new closure system.
Post-launch, Vetter will continue to offer both V-OVS and V-OVS next.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !